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Recent data support a role for DNA mismatch repair in
the cellular response to some forms of exogenous DNA
damage beyond that of DNA repair; cells with defective
DNA mismatch repair have partial or complete failure
to undergo apoptosis and/or G2M arrest following spe-
ci¢c types of damage. We propose that the DNA mis-
match repair Msh2/Msh6 heterodimer, responsible for
the detection of DNA damage, promotes apoptosis in
normal cells, thus protecting mammals from ultravio-
let-induced malignant transformation. Using primary
mouse embryonic ¢broblasts derived from Msh6þ /þ
and Msh6^/^ mice, we compare the response of DNA-
mismatch repair-pro¢cient and -de¢cient cells to ultra-
violet B radiation. In the wild-type mouse embryonic
¢broblasts, ultraviolet-B-induced increases in Msh6
protein levels were not dependent on p53. Msh6^/^
mouse embryonic ¢broblasts were signi¢cantly less sen-
sitive to the cytotoxic e¡ects of ultraviolet B radiation.
Further comparison of the Msh6þ /þ and Msh6^/^ mouse
embryonic ¢broblasts revealed that Msh6^/^ mouse em-
bryonic ¢broblasts undergo signi¢cantly less apoptosis
following ultraviolet B irradiation, thus indicating that
ultraviolet-B-induced apoptosis is partially Msh6 de-
pendent. These data support a role for Msh6 in protec-
tive cellular responses of primary cells to ultraviolet-B-
induced mutagenesis and, hence, the prevention of skin
cancer. Key words: apoptosis/cytotoxicity/DNA mismatch re-
pair/Msh6/ultraviolet B. J Invest Dermatol 121:876 ^880, 2003
C
ellular competence at both detecting and respond-
ing to postreplicative and exogenous DNA damage
is necessary for maintenance of genomic stability
and avoidance of malignant transformation. DNA
mismatch repair (MMR) is a postreplicative repair
mechanism responsible for repair of small loops or single base
mismatches in DNA. MMR is critical in preventing microsatel-
lite instability, a hallmark of genomic instability, and cells with
defective MMR have increased mutation rates and tumorigenesis
(reviewed in Aquilina and Bignami, 2001; Peltomaki, 2001).
Furthermore, the hereditary cancer syndrome known as heredi-
tary nonpolyposis colorectal cancer is associated with germline
mutations in MMR genes, illustrating the importance of mam-
malian MMR in maintaining genomic integrity and protecting
cells from malignant transformation. Mice engineered to be de¢-
cient in MMR are prone to malignancy, providing a good model
to study the role of MMR in human disease.
In addition to MMR having a critical role in postreplicative
DNA repair, recent data support a role for MMR in the ability
of cells to respond appropriately to DNA damage through cell
cycle arrest and apoptosis. For example, MMR-de¢cient cell lines
are resistant to some cytotoxic agents (e.g., alkylating agents) and
may exhibit de¢cits in JNK activation, p53 accumulation, p53
phosphorylation, p21 (Waf1/Cip1) accumulation, and regulation
of the G2M checkpoint (reviewed in Li, 1999; Bellacosa, 2001).
Also, cancer cell lines de¢cient in MMR have a reduced ability
to undergo apoptosis in response to some forms of chemical car-
cinogens and oxidative stress (DeWeese et al, 1998; Hickman and
Samson, 1999;Toft et al, 1999;Wu et al, 1999; Zeng et al, 2000; Duc
and Leong-Morgenthaler, 2001; Hardman et al, 2001), suggesting
that apoptosis protects against tumorigenesis by eliminating mu-
tated cells. Finally, overexpression of MSH2 or MLH1 results in
apoptosis (Zhang et al, 1999), indicating a possible connection be-
tween accumulation of MMR proteins and activation of apopto-
tic signaling pathways.
The role of MMR in the repair of DNA damage induced by
ultraviolet (UV) radiation has been controversial (reviewed in
Young et al, 2003; Mu et al, 1997; Shin et al, 2002; Sonneveld
et al, 2001; Wang et al, 1999; Mellon et al, 1996; Mellon and
Champe, 1996; Sweder et al, 1996). Much of the research into the
role of MMR in UV-induced DNA damage has been performed
using UVC (germicidal, 200^280 nm) radiation. UVB (280^320
nm), however, is considered the most important type of UV ra-
diation in skin carcinogenesis because it carries su⁄cient energy
to damage human cells and is ubiquitous in the environment.
Also, studies in mammalian systems have been predominantly
performed in tumor-derived or transformed cells. The contribu-
tion of MMR to UVB-induced protective cellular responses,
however, may be masked in cells with inactivated or mutated
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p53.The tumor suppressor protein p53 is mutated and/or de¢cient
in over 50% of human cancers, including skin cancer, and is im-
portant in the cellular response to UVB-induced damage (Li et al,
1995; 1996). Indeed, p53 may modulate the MMR-dependent re-
sponse to some types of DNA damage and MMR may in£uence
p53 accumulation and phosphorylation (D’Atri et al, 1998; Toft
et al, 1999;Wu et al, 1999; Lin et al, 2000; 2001), indicating the im-
portance of wild-type p53 status when investigating the contri-
bution of MMR de¢ciency to cancer predisposition.
We propose that Msh6, part of the Msh2/Msh6 heterodimer
responsible for initial recognition of and binding to mismatched
DNA or DNA adducts, is involved in mediating apoptosis, an
important component of the protective responses elicited by
UVB-induced DNA damage. We have compared the levels of
cytotoxicity and apoptosis in Msh6^/^ and Msh6þ /þ primary
mouse embryonic ¢broblasts (MEFs) and found that the
Msh6^/^ MEFs had increased levels of cell viability and reduced
levels of apoptosis following UVB irradiation.These data support
a role for MMR in protecting against UVB-induced tumorigen-
esis, and thus in preventing skin cancer.
MATERIALS AND METHODS
Primary cells Primary MEFs were generated from 13 d embryos from
mice with a targeted disruption of Msh6 (Edelmann et al, 1997) and from
p53 knockout mice (The Jackson Laboratory, Bar Harbor, ME). Individual
embryos were disaggregated in trypsin, large cellular debris was removed,
and the remaining cells were plated at 15106 cells per 75 mm2 in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) plus 20% fetal bovine
serum (FBS) and penicillin/streptomycin (Gibco/Invitrogen, Burlington,
ON, Canada). Cellular debris was used to genotype the Msh6 (Edelmann
et al, 1997) and p53 (Jacks et al, 1994) embryos. Cells were maintained in
DMEM plus 20% FBS (Gibco/Invitrogen) and cryopreserved within 48 h
of generation. Once retrieved from liquid nitrogen storage, cells were
expanded for 4^5 d before plating for UVB experiments. Before plating
for UVB irradiation, the MEFs were not split more than twice (1:3) as
MMR-de¢cient cells have a mutator phenotype and may acquire
additional genetic aberrations during replication. During this time, the
MEF were monitored closely. Growth rates and appearance were
equivalent between experiments and between the Msh6þ /þ and Msh6^/^
MEF, thus indicating reproducible and predictable cell growth. Animal
procedures were approved by the Health Sciences Laboratory Animal
Services at the University of Alberta.
UVB irradiation Medium was removed from cells at 75% con£uence
and remaining adherent cells were washed twice with phosphate-bu¡ered
saline (PBS) and exposed to the UVB source, a bank of six un¢ltered UVB
bulbs (FS20T12/UVB-BP, Light Sources, Orange, CT). The output of the
UVB source was measured using an IL1700 Research Radiometer with an
SED 240/UVB-1/Wdetector (International Light, Newburyport, MA). In
all cases the value was determined with the UV sensor covered with the lid
of a tissue culture plate used for the cells, which ¢lters out UVC. The
medium was replaced immediately after irradiation. Untreated control
cells were subjected to a similar protocol.
Cytotoxicity assays Relative cell growth was analyzed by comparing
the post-UVB Msh6^/^ MEF density to that of the untreated Msh6þ /þ
MEFs. MEFs were grown on 35 mm plates, and 48 h after UVB
irradiation the medium was removed and cells were stained for 20 min
with crystal violet in 20% methanol. The plates were washed with
distilled water to remove excess dye and air dried. Densitometry was
performed using a Max2 Flour-S Multimager (Quantity One software
version 4.2, Bio-Rad, Mississauga, ON, Canada).
To determine single cell viability, suspension and adherent cells were
collected 48 h post-UVB, stained with a Live/Dead Viability/Cytotoxicity
Kit (Molecular Probes, Eugene, OR) and analyzed by £uorescence-activated
cell sorter (FACS; Becton Dickinson, BD Biosciences, San Jose, CA).
Apoptosis assays Forty-eight hours post-UVB, adherent and suspension
cells were collected. The percentage of apoptotic cells was determined by
FACS analysis using an AnnexinFITC Apoptosis Kit (BD Pharmingen,
San Diego, CA). Cleavage of poly(ADP-ribose) polymerase-1 (PARP) and
caspase-3 was determined by western blot analysis 24 h post-UVB, as
described below.
Western blot analysis Adherent and £oating cells were collected and
lyzed (1% sodium dodecyl sulfate (SDS), 10 mM MgCl2, 50 mM Tris, pH
7.5) with brief sonication in the presence of protease inhibitors (Complete
Mini protease inhibitor cocktail tablets, Roche Diagnostics, Laval, PQ,
Canada). Lysates were diluted in solubilizing bu¡er (¢nal concentration
2.5% (wt/vol) SDS, 5% (vol/vol) 2-mercaptoethanol), separated by dis-
continuous SDS polyacrylamide gel electrophoresis, and electro-trans-
ferred onto either Immobilon-P membrane (Millipore, Etobicoke, ON,
Canada) or Immun-Blot PVDF membrane (0.2 mm, Bio-Rad, Mississauga,
ON, Canada) inTris/glycine/SDS transfer bu¡er. Blots were blocked in 4%
(wt/vol) dry milk/TBST. Primary antibodies used were as follows: cleaved
caspase-3, p42 MAP kinase 3A7/ERK2 (#9661 and #9107, Cell Signaling,
Beverly, MA); Msh2 (#NA27, Oncogene Research Products, San Diego,
CA); MSH6, PARP (#610919, #65196E, BD Biosciences). Antibody
binding was visualized using the appropriate horseradish-peroxidase-
conjugated secondary antibody and the Western Lightning luminol
reagent (Perkin Elmer, Boston, MA) on Fuji SuperRX ¢lm (Fuji¢lm,
Stamford, CT).
RESULTS
A p53-independent increase in Msh6 protein levels post-
UVB Following exposure to UVB, wild-type MEFs demons-
trated increased levels of Msh6, which were maximal 24 h after
irradiation. Msh6 protein levels returned to those of the
nonirradiated controls by 48 h post-UVB (Fig 1).
Post-UVB levels of Msh6 were also compared in p53þ/þ and
p53^/^ primary MEFs. We found that both Msh2 and Msh6
proteins were present in the p53^/^ MEFs, and that Msh6 levels
were increased following UVB irradiation, indicating a p53-
independent response of MMR (Fig 2, Table I). We have also
observed p53- independent accumulation of Msh6 in p53 ^/^
dermal ¢broblasts (data not shown).
Figure1. MMR protein Msh6 is induced post-UVB. A representative
western blot showing a time course analysis of MMR protein accumula-
tion in Msh6þ /þ and Msh6^/^ primary MEF following 100 J/m2 of UVB.
The UVB-dependent increase in Msh6 protein levels was reproducible
over several independent experiments.
Figure 2. Increased levels of Msh6 post-UVB are p53-independent.
Dose^response of Msh6 and Msh2 protein accumulation in p53þ/þ and
p53^/^ MEFs 24 h post-UVB.
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UVB-induced apoptosis and cytotoxicity is partially
dependent on MMR status The cytotoxic e¡ects of UVB on
Msh6þ /þ and Msh6^/^ MEFs were investigated using both an
assay for relative cell growth and a single cell viability assay.
Using both methods, it was found that the Msh6^/^ MEFs
demonstrated a modest but signi¢cant (po0.05) decrease in
UVB-induced cytotoxicity (Fig 3).
To examine further the importance of Msh6 to the post-UVB
response, we compared the levels of apoptosis in the Msh6þ /þ
and Msh6^/^ MEFs. After dual staining of un¢xed cells with
propidium iodide and labeled annexin V, FACS analysis revealed
that the wild-type MEFs undergo apoptosis post-UVB and that
the apoptotic response is concentration dependent (Fig 4A). In
comparison, a signi¢cantly (po0.05) reduced percentage of
Msh6^/^ MEFs undergo apoptosis 48 h post-UVB. This decrease
in apoptotic response was particularly pronounced at 100 J/m2
(p¼ 0.013).
The decreased levels of UVB-induced apoptosis and cytotoxi-
city were reproducible between experiments, including those
using Msh6^/^ MEFs generated from independent embryos.
Caspase-3 and PARP cleavage are both hallmarks of apoptosis.
The decreased levels of apoptosis in the Msh6^/^ MEFs are
con¢rmed by our observation that levels of cleaved caspase-3
were higher in the Msh6þ /þ MEFs than in the Msh6^/^ MEFs
24 h after irradiation with 250 J/m2 UVB (Fig 4B). The 116 kDa
PARP protein is cleaved during apoptosis resulting in an 85 kDa
product. Taking the levels of the Erk-2 loading control into
Table I. Increased Msh6 protein levels in p53þ/þ and
p53/ MEFs
UVB dose ( J/m2) p53þ/þ MEFs p53/ MEFs
0 1 1.8
50 1.7 2.7
100 1.5 2.6
Numbers are relative to the p53þ/þ 0 J/m2 control.
Figure 3. Msh6^/^ MEFs are less sensitive to UVB-induced cell death.
Relative cell growth (A) and single cell viability (B) of Msh6þ /þ and
Msh6^/^ primary MEFs 48 h post-UVB. Data shown are the mean of three
experiments7SEM. Signi¢cance of the di¡erences between the two cell
types was determined by a two-tailed, unpaired t test. po0.1, po0.05.
Figure 4. Msh6^/^ MEFs undergo less UVB-induced apoptosis. (A)
Percentage of cells undergoing apoptosis by annexin V/PI staining and
FACS analysis. Data shown are the mean of three experiments7SEM. Sig-
ni¢cance of the di¡erences between the two cell types was determined by a
two-tailed, unpaired t test. po0.1, po0.05. (B) Taking into account
protein loading, as determined by Erk-2 levels and quanti¢ed as ratios,
Msh6^/^ MEF demonstrate lower levels of PARP cleavage and caspase-3
cleavage 24 h after irradiation with 175 or 250 J/m2 UVB.
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account, levels of cleaved 85 kDa PARP were higher in the
Msh6þ /þ MEFs 24 h after irradiation with either 175 or
250 J/m2 (Fig 4B). No other cleavage products were visible.
Di¡erences between the Msh6þ /þ and Msh6^/^ MEFs are not
likely noticeable at lower UVB doses 24 h after irradiation
because of the low levels of apoptosis at this time point; less
than 20% of wild-type MEFs are apoptotic 24 h after exposure
to 250 J/m2 UVB (data not shown). Taken together, these data
con¢rm that both the Msh6þ /þ and Msh6^/^ MEFs undergo
apoptosis in response to UVB irradiation and that levels of
apoptosis are decreased in the Msh6^/^ MEFs.
DISCUSSION
In addition to its role in postreplicative DNA repair, MMR is
involved in cellular responses to DNA damage induced by some
chemical carcinogens. Since MMR proteins bind some chemi-
cally induced adducts, and MMR de¢ciency increases chemically
induced mutagenesis by such agents (e.g., cisplatin (Mu et al, 1997;
Lin et al, 2001)), MMR is thought to contribute to the repair of
such adducts. Increasingly, however, data point to a role for
MMR as a sensor for DNA damage and in the signaling of post-
damage responses beyond repair of the DNA adducts (reviewed
in Li, 1999; Bellacosa, 2001). These data demonstrate a role for the
MMR protein Msh6 in in£uencing levels of cytotoxicity and
apoptosis in response to UVB exposure.
MMR is involved in the signaling pathways activated in re-
sponse to some forms of exogenous DNA damage. However,
the degree to which the damage response is dependent on
MMR, is modulated by the type of DNA adduct. The e¡ect of
disabled MMR on the response of cells to various carcinogens
can be divided into four general categories: (1) failure to apoptose
and high-level resistance (e.g., MNNG, hydrogen peroxide
(Hickman and Samson, 1999; Hardman et al, 2001)); (2) partial
loss of both apoptosis and cytotoxicity (e.g., £uoropyrimidne,
cisplatin (Toft et al, 1999; Lin et al, 2001; Meyers et al, 2001)); (3)
partial loss of apoptosis, but cytotoxicity not altered (e.g.,
BCNU, methotrexate, PhIP (Hickman and Samson, 1999; Duc
and Leong-Morgenthaler, 2001; Frouin et al, 2001)); and (4) in-
creased sensitivity (e.g., topoisomerase inhibitors (Jacob et al,
2001)). In some cases, the MMR-dependent cytotoxicity is inde-
pendent of functional p53. For example, resistance of MMR-
de¢cient cells to oxidative damage is partially p53 independent
(Lin et al, 2000). Conversely, MMR-de¢cient cells have impaired
cisplatin-induced apoptosis that is p53 dependent (Fink et al, 1997;
Zamble et al, 1998; Toft et al, 1999).
The role of MMR in the repair of UV-induced DNA damage
is controversial and probably species-speci¢c. In bacteria, MMR
appears to be required for transcription coupled repair (Mellon
and Champe, 1996; Mellon et al, 1996). Saccharomyces cerevisiae
strains, however, are not defective in transcription coupled repair
of UV-induced DNA damage (Sweder et al, 1996; Leadon and
Avrutskaya, 1998). In the mammalian system, there is some evi-
dence that rapid transcription coupled repair may be reduced in
MMR-de¢cient cell lines (Mellon et al, 1996; Leadon and Avruts-
kaya, 1997), although an increasing number of studies suggest
otherwise (Li and Bockrath, 1995; Mu et al, 1997; Adimoolam et al,
2001; McKay et al, 2001; Sonneveld et al, 2001;Therrien et al, 2001;
Rochette et al, 2002; Shin et al, 2002). In bothMsh6^/^ andMsh2^/^
primary MEF, we have not detected a consistent di¡erence in
the global repair of thymine dimers in comparison to matched
wild-type cells (L.C. Young, unpublished data; A.C. Peters,
unpublished data). However, the Msh2/Msh6 heterodimer has
been shown to bind to UV adducts (Mu et al, 1997; Wang et al,
1999), and MMR proteins physically interact with nucleotide
excision repair proteins (NER) (Mellon et al, 1996; Bertrand
et al, 1998). Also, loss of MMR on a NER-de¢cient background
further decreases skin tumor latency and increases mutation rates
following UV exposure (Meira et al, 2001; Nara et al, 2001).
Based on these previous data, we propose that MMR may
promote the elimination of mutated cells, therefore reducing
the impact of UVB-induced DNA damage and protecting
against UVB-induced malignant transformation. In this study,
Msh6 protein levels increased in response to UVB and this in-
crease was not dependent on functional p53 (Fig 1,Table I). Such
p53 independence was unexpected as p53 has been demonstrated
to be necessary for transcriptional activation of MSH2 in re-
sponse to UVB (Scherer et al, 2000) and MSH6 exists in a hetero-
dimer with MSH2. In vivo, murine Msh2 protein levels are
increased in the basal layer of the epidermis as early as 1 h post-
UVB and remain elevated for 48 h, and this rapid induction pre-
cedes the accumulation of both p53 and p21 (Lu et al, 1999).
Comparing Msh6þ /þ and Msh6^/^ primary MEFs, we ob-
served that Msh6^/^ MEF are partially resistant to the cytotoxic
e¡ects of UVB radiation (Fig 3) and that Msh6 is necessary for
a complete apoptotic response in response to UVB (Fig 4). Frit-
zell et al (1997) found that SV40-transformed Pms2^/^ MEFs were
not more resistant to UVC than wild-type control cells. Msh6 is
part of a dimer with Msh2, which binds initially to the site of
DNA damage. The recruitment of the Pms2/Mlh1 heterodimer
is thought to be a secondary event. If the Msh2/Msh6 heterodi-
mer is part of a sensory complex that detects UV-induced DNA
adducts and if MMR is not directly involved in the repair of
UV-induced DNA damage, it is not surprising that Msh6^/^ cells,
but not Pms2^/^ cells, demonstrate UV resistance. Loss of MMR
has not been found to decrease UVcytotoxicity in tumor-derived
cell lines (Mellon et al, 1996; Young et al, 2003) and this, together
with our data, suggests that mammalian MMR in response to
UV radiation is to protect against malignant transformation. Ad-
ditional mutations acquired during transformation may disable
the pathway responsible for MMR-dependent apoptosis in re-
sponse to UV in MMR-pro¢cient cells.
Although MMR may not be directly involved in the repair of
UV-induced DNA damage, data have shown that MMR-de¢-
cient cells have increased levels of mutagenesis in response to
UV (Nara et al, 2001). Also, Msh2^/^ mice are predisposed to
UVB-induced skin tumors (Meira et al, 2001; Yoshino et al,
2002), supporting a role for MMR in the suppression of UVB-
induced tumorigenesis. Our observation that Msh6^/^ primary
MEFs undergo less UVB-induced apoptosis than the Msh6þ /þ
MEFs suggests that this resistance to cell death contributes to tu-
morigenesis in MMR-de¢cient cells. Msh6 may be a component
of the signaling pathway that initiates apoptosis in response to
UVB-induced DNA damage. Studies are ongoing to determine
the defects in apoptotic signaling in these Msh6^/^ MEFs and to
determine the relationship between MMR proteins and p53 in
the cellular response to UVB-induced damage. Of particular in-
terest is our observation that Msh2 and Msh6 protein levels were
higher in p53^/^ than in p53þ /þ primary MEFs suggesting a
possible compensatory e¡ect for MMR in tumors typi¢ed by a
loss of functional p53, as is the case with skin cancers.
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